Welcome to the Entresto on-demand webinars page. Below you can access recordings from educational webinars that were hosted by experts in the field of heart failure and were organised by Novartis.
You will be required to register to watch the videos.
What can I do to keep my chronic HFrEF patients out of hospital?
Watch Jacqui Hyland, Dr Matt Fay and Dr Simon Williams discuss chronic heart failure management in primary care. Listen to the experts exchange views on how the future of heart failure management is evolving, and where they position Entresto in the chronic heart failure treatment pathway.
Early initiation of Entresto® (sacubitril/valsartan): alter the cycle of readmission in patients with heart failure
Watch Dr Aaron Wong present key findings from two studies in treatment of patients with chronic heart failure, and share his local data on the early initiation of Entresto.
Five years of experience with Entresto (sacubitril/valsartan): looking back and moving forward – virtual symposium
A recording from the Novartis symposium at the British Society for Heart Failure’s 23rd annual autumn meeting, which took place virtually.
Prominent cardiologists Dr Patricia Campbell and Professor Mark Petrie exchange their experiences on using Entresto in the field of chronic heart failure.
Making every contact count: the role of primary care in the management of patients with chronic heart failure
The webinar event was held on the 9th September 2020 and was organised by Novartis.
Hear Dr Matt Fay discuss the Bradford CCG heart failure pathway, Professor Roy Gardner talk about licensed treatments for chronic heart failure and Dr Majid Akram share how to get the most out of virtual consultations.
Indication: Entresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.1
CCG, clinical commissioning group; HFrEF, heart failure with reduced ejection fraction.
- Entresto Summary of Product Characteristics, 2020.